drugset / Trial / NCT07136805
A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multicenter, randomized, single-masked, active-controlled, parallel, Phase III pivotal study in China
Timeline
- Start
- 2025-10-01
- Primary completion
- 2026-12-31
- Completion
- 2027-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prednisolone | Other / unclassified | 1 % | Other |
| Subject | VVN461 | Unknown | 1 % | Other |